J Rheumatol 2022 Jun 15. Epub 2022 Jun 15.
DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, University Hospital of Copenhagen Rigshospitalet, Glostrup, Denmark, Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Rheumatology, Center for Rheumatology and Spine Diseases Gentofte and Herlev Hospital, Denmark; Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark Sønderborg, Denmark; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark; Department of Rheumatology, Zealand University Hospital, Køge, Denmark; Department of Rheumatology, Odense University Hospital, Odense, Denmark; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark; Diagnostic Center, Silkeborg Regional Hospital, Silkeborg, Denmark; Department of Medicine, Horsens Regional Hospital, Horsens, Denmark; Zitelab, Copenhagen, Denmark; Gigtforeningen/Danish Rheumatism Association, Denmark Competing Interests: Bente Glintborg: Research grants: AbbVie, BMS, Pfizer; Oliver Hendricks: Research Grants: AbbVie, Novartis, Pfizer; Lene Terslev: speakers fee: Speakers fee from Roche, Novartis, Pfizer, and UCB;Mikkel Østergaard: Research grants: Abbvie, BMS, Celgene, Merck, Novartis; Consultancy and/or speaker fees: Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Galapagos, Gilead, Hospira, Janssen, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCB. Rene Østgård: research grants: Abbvie; Consultancy and/or speaker fees: Abbvie, BMS, Boehringer-Ingelheim, Eli-Lilly, Janssen, Merck, Novartis, Pfizer, Roche, Sanofi and UCB. Anne Gitte Loft: consultancy and/or speakers fees: AbbVie, Eli-Lilly, Janssen, MSD, Novartis, Pfizer, and UCB Merete Lund Hetland: AbbVie, Biogen, BMS, Celtrion, Eli Lilly Denmark A/S, Janssen Biologics B.V, Lundbeck Fonden, MSD, Pfizer, Roche, Samsung Biopis, Sandoz. MLH chairs the steering committee of the Danish Rheumatology Quality Registry (DANBIO), which receives public funding from the hospital owners and funding from pharmaceutical companies. MLH co-chairs EuroSpA, which generates real-world evidence of treatment of psoriatic arthritis and axial spondylorthritis based on secondary data and is partly funded by Novartis. Funding: Partly funded by an unrestricted grant by The Lundbeck Foundation (grant-number R349-2020-629).
Objective: To explore anxiety and self-isolation 15 months into the COVID-19 pandemic including attitudes towards and impact of SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease (IRD).
Methods: Nationwide online survey at three time points (May 2020, November 2020, May 2021). Patients with IRD followed in the Danish DANBIO registry were asked about the impact of the pandemic (SARS-CoV-2-infection, behavior, anxiety, concerns). Read More